Cite
HARVARD Citation
Borg, M. et al. (2021). Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity‐induced insulin resistance. Journal of cachexia, sarcopenia and muscle. 12 (5), pp. 1232-1248. [Online].